BOTOX ONE
Allergan, Inc.
Application Filed: 2021-11-09
Trademark Application Details
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97115552 |
| Mark Literal Elements | None |
| Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Standard Character Claim | No |
| Current Location | Not Found |
| Basis | No |
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
Timeline
| 2021-11-09 | Application Filed |
| 2021-11-17 | Status: Live/Pending |
| 2021-11-17 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
| 2021-11-18 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Allergan, Inc. |
| Address | 2525 Dupont Drive Irvine DE 92612 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2021-11-09 |
 Drawing | JPEG | 2021-11-09 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 38 |
| U.S. Codes: | 100,101,104 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0351 | Promoting and enhancing healthcare professionals understanding and awareness of botulinum toxin through educational offerings via a website, access to product support, social media, and dissemination of emails in conjunction therewith |
| GS0351 | Promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via print, audio, video, digital, on-line medium, and electronic mail; Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; distribution of samples for trial purposes in the field of neurology, dermatology and urology |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-11-18 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-11-24 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-11-29 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-11-29 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-11-29 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-05-16 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-05-16 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-05-16 | 8 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2022-06-07 | 9 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2022-06-07 | 10 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-06-07 | 11 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2022-08-29 | 12 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-08-29 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-08-30 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-09-01 | 15 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-09-14 | 16 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-10-04 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-10-04 | 18 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-11-29 | 19 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2023-04-21 | 20 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-05-10 | 21 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2023-04-21 | 22 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2023-05-16 | 23 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2023-11-01 | 24 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2023-11-01 | 25 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-11-01 | 26 GNRN O:Outgoing Correspondence |
| SU-EXAMINER'S AMENDMENT WRITTEN | 2023-11-08 | 27 SNEA W: |
| EXAMINERS AMENDMENT E-MAILED | 2023-11-08 | 28 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-11-08 | 29 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2023-11-08 | 30 XAEC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2023-11-08 | 31 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-11-09 | 32 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-12-12 | 33 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-12-12 | 34 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BOTOX ONE 97115781 not registered Live/Pending |
Allergan, Inc. 2021-11-09 |
 BOTOX ONE 97115552 not registered Live/Pending |
Allergan, Inc. 2021-11-09 |
 BOTOX ONE 87379786 5734450 Live/Registered |
Allergan, Inc. 2017-03-21 |
 BOTOX ONE 87374234 5734444 Live/Registered |
Allergan, Inc. 2017-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 